GATA3 and neoplasm: The stable expression of Gata3 in the total ILC2s across different conditions remained mostly unchanged (log2FC < 0.01, Table 1) suggesting that ILC2 largely maintained their type 2 identity during tumour development and activation, at least at the transcriptional factor level, in the lungs.